Get the Stockscreener App
6.29
0.63%
-0.04
After Hours:
6.29
Lyra Therapeutics Inc stock is traded at $6.29, with a volume of 65,899.
It is down -0.63% in the last 24 hours and down -6.81% over the past month.
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.
See More
Previous Close:
$6.33
Open:
$6.34
24h Volume:
65,899
Relative Volume:
0.86
Market Cap:
$10.34M
Revenue:
$1.47M
Net Income/Loss:
$-97.61M
P/E Ratio:
-4.2215
EPS:
-1.49
Net Cash Flow:
$-80.90M
1W Performance:
-8.18%
1M Performance:
-6.81%
6M Performance:
-30.80%
1Y Performance:
-51.62%
1-Day Range:
$6.15
$6.72
1-Week Range:
$6.03
$6.93
52-Week Range:
$3.8101
$37.50
Lyra Therapeutics Inc Stock (LYRA) Company Profile
Name
Lyra Therapeutics Inc
Sector
Industry
Phone
617-373-4600
Address
480 ARSENAL WAY, WATERTOWN, MA
Compare LYRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LYRA
Lyra Therapeutics Inc
|
6.29 | 10.54M | 1.47M | -97.61M | -80.90M | -1.49 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Lyra Therapeutics Inc Stock (LYRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-07-24 | Downgrade | BofA Securities | Buy → Underperform |
| May-07-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| May-07-24 | Downgrade | Jefferies | Buy → Hold |
| May-06-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-06-23 | Resumed | BTIG Research | Buy |
| Aug-31-23 | Initiated | H.C. Wainwright | Buy |
| May-24-22 | Initiated | Cantor Fitzgerald | Overweight |
| May-26-20 | Initiated | BTIG Research | Buy |
| May-26-20 | Initiated | BofA/Merrill | Buy |
| May-26-20 | Initiated | Jefferies | Buy |
| May-26-20 | Initiated | William Blair | Outperform |
View All
Lyra Therapeutics Inc Stock (LYRA) Latest News
How to manage a losing position in Lyra Therapeutics Inc.Portfolio Value Report & Weekly Hot Stock Watchlists - Newser
Can Lyra Therapeutics Inc. hit a new high this monthJuly 2025 Selloffs & Verified Trade Idea Suggestions - Newser
Reversal indicators forming on Lyra Therapeutics Inc. stockQuarterly Earnings Summary & Community Supported Trade Ideas - Newser
Exit strategy if you’re trapped in Lyra Therapeutics Inc.2025 Breakouts & Breakdowns & Trade Opportunity Analysis Reports - Newser
Combining price and volume data for Lyra Therapeutics Inc.2025 Momentum Check & High Win Rate Trade Alerts - Newser
Best data tools to analyze Lyra Therapeutics Inc. stock2025 Institutional Moves & Growth Focused Investment Plans - Newser
Applying sector rotation models to Lyra Therapeutics Inc.Trade Exit Summary & Entry Point Confirmation Alerts - Newser
Does Lyra Therapeutics Inc. show high probability of rebound2025 Institutional Moves & Fast Momentum Stock Entry Tips - Newser
Is Lyra Therapeutics Inc. stock bottoming outEarnings Risk Report & Daily Oversold Stock Bounce Ideas - Newser
Tick level data insight on Lyra Therapeutics Inc. volatilityMarket Performance Recap & Breakout Confirmation Alerts - Newser
Tools to assess Lyra Therapeutics Inc.’s risk profileFed Meeting & Weekly High Potential Stock Alerts - Newser
Is Lyra Therapeutics Inc. showing signs of accumulation2025 Technical Patterns & Safe Capital Preservation Plans - Newser
Is Lyra Therapeutics Inc. stock entering bullish territoryWeekly Profit Analysis & Technical Confirmation Alerts - Newser
How to forecast Lyra Therapeutics Inc. trends using time seriesTrade Volume Report & Risk Controlled Stock Pick Alerts - Newser
Lyra Therapeutics Receives Nasdaq Deficiency Letter - MSN
Lyra Therapeutics Inc. stock chart pattern explainedPortfolio Profit Report & Precise Swing Trade Alerts - Newser
Will breakout in Lyra Therapeutics Inc. lead to full recoveryJuly 2025 Rallies & Safe Capital Allocation Plans - Newser
Key metrics from Lyra Therapeutics Inc.’s quarterly dataJuly 2025 Gainers & Safe Entry Trade Signal Reports - Newser
Institutional scanner results for Lyra Therapeutics Inc.2025 EndofYear Setup & Daily Risk Controlled Trade Plans - Newser
What MACD and RSI say about Lyra Therapeutics Inc.Market Movement Recap & High Accuracy Buy Signal Tips - Newser
Signal strength of Lyra Therapeutics Inc. stock in tech scanners2025 Year in Review & Consistent Profit Focused Trading Strategies - Newser
Will Lyra Therapeutics Inc. stock recover after recent dropJuly 2025 Outlook & Short-Term Trading Alerts - Newser
Building trade automation scripts for Lyra Therapeutics Inc.Market Movement Recap & Expert Verified Movement Alerts - Newser
Developing predictive dashboards with Lyra Therapeutics Inc. dataMarket Performance Summary & Reliable Volume Spike Trade Alerts - Newser
Strategies to average down on Lyra Therapeutics Inc.Gap Up & Community Shared Stock Ideas - Newser
How to build a dashboard for Lyra Therapeutics Inc. stock2025 Earnings Surprises & Safe Swing Trade Setup Alerts - Newser
Chronic Rhinosinusitis Market Insights – Regeneron, Sanofi, GSK, and Lyra Therapeutics Driving Innovation | DelveInsight - The Globe and Mail
Lyra Therapeutics Inc.’s Price Action Aligns with Quant SignalsJuly 2025 Movers & Weekly Momentum Picks - beatles.ru
Lyra Therapeutics Inc. Trading Near Value Zone — Recovery Ahead2025 Risk Factors & Weekly High Return Opportunities - beatles.ru
Bollinger Band Squeeze Points to Volatility in Lyra Therapeutics Inc.Weekly Stock Recap & Community Trade Idea Sharing - beatles.ru
What Fibonacci levels say about Lyra Therapeutics Inc. reboundGap Down & Free AI Powered Buy and Sell Recommendations - Newser
Should you wait for a breakout in Lyra Therapeutics Inc.2025 Market Trends & Fast Entry Momentum Trade Alerts - Newser
Full technical analysis of Lyra Therapeutics Inc. stock2025 Trade Ideas & Free AI Powered Buy and Sell Recommendations - Newser
Why is Neuphoria Therapeutics Inc. stock going upPortfolio Update Summary & Expert Approved Trade Ideas - خودرو بانک
Lyra Therapeutics Inc. Stock Flags Risk Zone in Volatility Index2025 Top Gainers & Growth Focused Stock Reports - beatles.ru
Lyra Therapeutics Posts Corporate Presentation on LYR-210 - The Globe and Mail
What MACD signals say about Lyra Therapeutics IncJuly 2025 Summary & Real-Time Volume Triggers - Newser
Can Lyra Therapeutics Inc. lead its sector in growthQuarterly Risk Review & Risk Controlled Stock Pick Alerts - خودرو بانک
Lyra Therapeutics (LYRA) Stock Price, News & Analysis - MarketBeat
What recovery options are there for Lyra Therapeutics Inc.July 2025 Market Mood & Scalable Portfolio Growth Ideas - Newser
Will Lyra Therapeutics Inc. rebound enough to break evenStop Loss & Daily Stock Trend Reports - Newser
News impact scoring models applied to Lyra Therapeutics Inc.2025 Volatility Report & Weekly Hot Stock Watchlists - Newser
Lyra Therapeutics shares fall 1.54% after-hours following a corporate presentation. - AInvest
Lyra Therapeutics : Corporate PresentationSeptember 2025 (ffc804) - MarketScreener
What momentum shifts mean for Lyra Therapeutics Inc.Weekly Profit Recap & Free Long-Term Investment Growth Plans - Newser
What MACD signals say about Lyra Therapeutics Inc.2025 Price Targets & AI Driven Stock Movement Reports - Newser
Can Lyra Therapeutics Inc. grow without external fundingCPI Data & AI Enhanced Trading Signals - خودرو بانک
Is Lyra Therapeutics Inc. forming a double bottom2025 Earnings Surprises & Reliable Intraday Trade Plans - خودرو بانک
Has Lyra Therapeutics Inc. formed a bullish divergenceTrade Analysis Summary & Real-Time Buy Zone Alerts - Newser
Lyra Therapeutics Inc Stock (LYRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):